Feb 26
|
Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
|
Feb 25
|
Regeneron Pharmaceuticals, Inc. (REGN): Among the Stocks That Will Go to The Moon According to Analysts
|
Feb 24
|
Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial
|
Feb 24
|
Regeneron Pharmaceuticals (REGN): Among the Best Growth Stocks to Invest In According to Analysts
|
Feb 24
|
The Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis
|
Feb 21
|
2 Healthcare Stocks with Big Upside and 1 to Skip
|
Jan 28
|
Earnings Preview: Regeneron (REGN) Q4 Earnings Expected to Decline
|
Jan 28
|
Implied Volatility Surging for Regeneron Pharmaceuticals (REGN) Stock Options
|
Jan 28
|
Is Regeneron Pharmaceuticals (REGN) Among the Best Depressed Stocks to Invest in Now?
|
Jan 28
|
Drugmakers Show Restraint on Price Increases in New Trump Era
|
Jan 27
|
Is Regeneron Pharmaceuticals (REGN) the Best Stock to Buy and Hold for 2025?
|
Jan 24
|
Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Falling Stock to Invest in Right Now?
|
Jan 23
|
America's Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search
|
Jan 21
|
REGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES
|